Mitchell S Levine Oncocyte Corp (OCX) insider trading activity

OCX Quotes by TradingView

Mitchell S Levine is Chief Financial Officer of Oncocyte Corp. Currently has a direct ownership of 87,080 shares of OCX, which is worth approximately $202,025. The most recent transaction as insider was on Mar 15, 2022, when has been sold 25,000 shares (Common Stock, No Par Value) at a price of $1.17 per share, resulting in proceeds of $29,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.1K
0% 3M change
0% 12M change
Total Value Held $202,025

Mitchell S Levine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2022
BUY
Open market or private purchase
$29,250 $1.17 p/Share
25,000 Added 22.31%
87,080 Common Stock, No Par V...
Apr 28 2021
SELL
Payment of exercise price or tax liability
-
4,620 Reduced 6.93%
62,080 Common Shares, no par ...
Apr 28 2021
BUY
Exercise of conversion of derivative security
-
20,000 Added 23.07%
66,700 Common Shares, no par ...
Dec 11 2020
BUY
Grant, award, or other acquisition
-
10,121 Added 17.81%
46,700 Common Stock
MSL

Mitchell S Levine

Chief Financial Officer
Irvine, CA

Track Institutional and Insider Activities on OCX

Follow Oncocyte Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

News

Receive news related to Oncocyte Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCX